We are live on
!
Find out more
WSA
Wall Street Associates Portfolio holdings
AUM
$151M
1-Year Est. Return
30.3%
This Fund
S&P 500
This Quarter
Est. Return
-10.74%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$523M
AUM Growth
-$538M
(-51%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-83.99%
Top 10 Holdings %
Top 10 Hldgs %
16.14%
Holding
381
New
50
Increased
12
Reduced
195
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEOS
Neos Therapeutics, Inc
NEOS
|
+$4.39M |
| 2 |
EGLT
Egalet Corporation
EGLT
|
+$4.21M |
| 3 |
Teladoc Health
TDOC
|
+$3.72M |
| 4 |
FRSH
Papa Murphy's Holdings, Inc
FRSH
|
+$3.37M |
| 5 |
CORI
Corium International, Inc.
CORI
|
+$3.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADPT
Adeptus Health Inc
ADPT
|
+$26.9M |
| 2 |
Repligen
RGEN
|
+$15.8M |
| 3 |
AAC
AAC Holdings
AAC
|
+$15.3M |
| 4 |
TWOU
2U Inc
TWOU
|
+$9.16M |
| 5 |
CALD
Callidus Software, Inc.
CALD
|
+$8.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.22% |
| 2 | Technology | 24.65% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Industrials | 10.1% |
| 5 | Communication Services | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Asbury Automotive
ABG
$3.85B
| $1.59M | 0.3% |
19,545
-5,246
| -21% | -$444K |
|
102
Euronet Worldwide
EEFT
$2.7B
| $1.58M | 0.3% |
21,346
-7,416
| -26% | -$496K |
|
103
Rapid7
RPD
$773M
| $1.54M | 0.29% |
+67,500
| New | +$1.5M |
|
104
Under Armour
UAA
$2.6B
| $1.5M | 0.29% |
31,022
+11,022
| +55% | +$524K |
|
105
Manhattan Associates
MANH
$11.4B
| $1.5M | 0.29% |
24,073
-10,559
| -30% | -$658K |
|
106
AMN Healthcare
AMN
$1.4B
| $1.5M | 0.29% |
49,928
-18,779
| -27% | -$620K |
|
107
DexCom
DXCM
$32B
| $1.47M | 0.28% |
68,260
-34,988
| -34% | -$781K |
|
108
G-III Apparel Group
GIII
$1.5B
| $1.45M | 0.28% |
23,498
-2,738
| -10% | -$188K |
|
|
ANAC
109
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.42M | 0.27% |
12,050
-17,482
| -59% | -$2.28M |
|
110
Interface
TILE
$2.22B
| $1.39M | 0.27% |
61,763
-7,500
| -11% | -$184K |
|
|
PRXL
111
DELISTED
Parexel International Corp
PRXL
| $1.38M | 0.26% |
22,339
-8,429
| -27% | -$567K |
|
112
Casey's General Stores
CASY
$30.9B
| $1.36M | 0.26% |
13,195
-1,384
| -9% | -$144K |
|
|
PFPT
113
DELISTED
Proofpoint, Inc.
PFPT
| $1.33M | 0.25% |
22,085
-8,206
| -27% | -$510K |
|
|
TEAR
114
DELISTED
TearLab Corporation
TEAR
| $1.32M | 0.25% |
65,830
-36,890
| -36% | -$863K |
|
|
ARGS
115
DELISTED
Argos Therapeutics, Inc.
ARGS
| $1.24M | 0.24% |
12,895
-9,930
| -44% | -$1.18M |
|
116
Helen of Troy
HELE
$693M
| $1.23M | 0.23% |
13,719
-1,700
| -11% | -$152K |
|
117
Albany International
AIN
$1.78B
| $1.22M | 0.23% |
42,543
-11,508
| -21% | -$390K |
|
|
CPHD
118
DELISTED
Cepheid Inc
CPHD
| $1.22M | 0.23% |
26,934
-3,300
| -11% | -$176K |
|
119
AtriCure
ATRC
$2.11B
| $1.19M | 0.23% |
54,495
-6,600
| -11% | -$165K |
|
120
RH
RH
$3.71B
| $1.19M | 0.23% |
+12,801
| New | +$1.26M |
|
121
Blackbaud
BLKB
$2.08B
| $1.19M | 0.23% |
21,265
-4,421
| -17% | -$259K |
|
122
SEI Investments
SEIC
$12.6B
| $1.19M | 0.23% |
24,663
-8,082
| -25% | -$411K |
|
123
Jack in the Box
JACK
$335M
| $1.16M | 0.22% |
15,073
-1,800
| -11% | -$154K |
|
|
PLKI
124
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $1.14M | 0.22% |
20,153
-2,500
| -11% | -$144K |
|
125
Churchill Downs
CHDN
$6.12B
| $1.13M | 0.22% |
+50,556
| New | +$1.12M |
|
Similar funds
CF
VWM
HH
NSCP
EEG
BC
WRHAM
SRP
Wall Street Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Wall Street Associates held 381 positions worth $523M, down 51% from $1.06B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wall Street Associates withdrew a net $439M in Q3 2015, closing 68 positions and reducing 195 holdings. Its most notable exit was AAC Holdings, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Wall Street Associates opened a new position in Neos Therapeutics, Inc worth $4.19M.
- Wall Street Associates's largest Q3 2015 buy was Neos Therapeutics, Inc: 199,343 shares worth $4.19M.
- Wall Street Associates added most to uniQure in Q3 2015, an estimated $780K increase.
- Wall Street Associates's biggest Q3 2015 reduction was Adeptus Health Inc, cutting an estimated $26.9M.
- Wall Street Associates fully exited AAC Holdings in Q3 2015, selling an estimated $15.3M.
- Wall Street Associates's ten largest holdings make up 16% of its $523M portfolio in Q3 2015.
- Wall Street Associates opened 50 new positions and closed 68 in Q3 2015.
- Wall Street Associates's portfolio value fell 51% quarter-over-quarter to $523M.
Based on Wall Street Associates's 13F filing for Q3 2015, filed 12 Nov 2015.